Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Res Sq ; 2023 Jul 18.
Artigo em Inglês | MEDLINE | ID: mdl-37502932

RESUMO

Calcium (Ca2+) uptake by mitochondria is essential in regulating bioenergetics, cell death, and cytosolic Ca2+ transients. Mitochondrial Calcium Uniporter (MCU) mediates the mitochondrial Ca2+ uptake. MCU is a heterooligomeric complex with a pore-forming component and accessory proteins required for channel activity. Though MCU regulation by MICUs is unequivocally established, there needs to be more knowledge of whether divalent cations regulate MCU. Here we set out to understand the mitochondrial matrix Mg2+-dependent regulation of MCU activity. We showed Mrs2 as the authentic mammalian mitochondrial Mg2+ channel using the planar lipid bilayer recordings. Using a liver-specific Mrs2 KO mouse model, we showed that decreased matrix [Mg2+] is associated with increased MCU activity and matrix Ca2+ overload. The disruption of Mg2+dependent MCU regulation significantly prompted mitochondrial permeability transition pore opening-mediated cell death during tissue IR injury. Our findings support a critical role for mMg2+ in regulating MCU activity and attenuating mCa2+ overload.

2.
J Neurosci Res ; 89(12): 1913-25, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21910135

RESUMO

Glucose is the primary metabolic fuel for the mammalian brain, and a continuous supply is required to maintain normal CNS function. The transport of glucose across the blood-brain barrier (BBB) into the brain is mediated by the facilitative glucose transporter GLUT-1. Prior studies (Simpson et al. [2001] J Biol Chem 276:12725-12729) had revealed that the conformations of the GLUT-1 transporter were different in luminal (blood facing) and abluminal (brain facing) membranes of bovine cerebral endothelial cells, based on differential antibody recognition. This study has extended these observations and, by using a combination of 2D-PAGE/Western blotting and immunogold electron microscopy, determined that these different conformations are exhibited in vivo and arise from differential phosphorylation of GLUT-1 and not from alternative splicing or altered O- or N-linked glycosylation.


Assuntos
Barreira Hematoencefálica/química , Barreira Hematoencefálica/metabolismo , Transportador de Glucose Tipo 1/química , Transportador de Glucose Tipo 1/metabolismo , Animais , Northern Blotting , Western Blotting , Bovinos , Eletroforese em Gel Bidimensional , Microscopia Imunoeletrônica , Fosforilação , Conformação Proteica , Isoformas de Proteínas/química , Isoformas de Proteínas/metabolismo
3.
J Neurochem ; 109 Suppl 1: 207-13, 2009 May.
Artigo em Inglês | MEDLINE | ID: mdl-19393029

RESUMO

The genetic absence epilepsy rat from Strasbourg is considered an isomorphic, predictive, and homologous model of typical childhood absence epilepsy. It is characterized by the expression of spike-and-wave discharges (SWDs) in the thalamus and cortex. The ketogenic diet (KD) is successfully used in humans and animals with various types of seizures, but was not effective in children with intractable atypical absence epilepsy. Here, we studied its potential impact on the occurrence of SWDs in genetic absence epilepsy rat from Strasbourg. Rats were fed the KD for 3 weeks during which they were regularly subjected to the electroencephalographic recording of SWDs. The KD did not influence the number and duration of SWDs despite a 15-22% decrease in plasma glucose levels and a large increase in beta-hydroxybutyrate levels. Likewise, the KD did not affect the level of expression of the blood-brain barrier glucose transporter GLUT1 or of the monocarboxylate transporters, MCT1 and MCT2. This report extends the observation in humans that the KD does not appear to show effectiveness in intractable atypical absence epilepsy to this model of typical childhood absence epilepsy which responds to specific antiepileptic drugs.


Assuntos
Epilepsia Tipo Ausência/dietoterapia , Epilepsia Tipo Ausência/genética , Transportadores de Ácidos Monocarboxílicos/genética , Transportadores de Ácidos Monocarboxílicos/metabolismo , Ácido 3-Hidroxibutírico/metabolismo , Animais , Glicemia/metabolismo , Barreira Hematoencefálica/metabolismo , Eletroencefalografia , Glucose/metabolismo , Transportador de Glucose Tipo 1/biossíntese , Transportador de Glucose Tipo 1/metabolismo , Corpos Cetônicos/metabolismo , Masculino , Transportadores de Ácidos Monocarboxílicos/biossíntese , Ratos , Simportadores/metabolismo
4.
J Cereb Blood Flow Metab ; 35(1): 48-57, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25315861

RESUMO

Neurologic disorders such as Alzheimer's, Parkinson's disease, and Restless Legs Syndrome involve a loss of brain iron homeostasis. Moreover, iron deficiency is the most prevalent nutritional concern worldwide with many associated cognitive and neural ramifications. Therefore, understanding the mechanisms by which iron enters the brain and how those processes are regulated addresses significant global health issues. The existing paradigm assumes that the endothelial cells (ECs) forming the blood-brain barrier (BBB) serve as a simple conduit for transport of transferrin-bound iron. This concept is a significant oversimplification, at minimum failing to account for the iron needs of the ECs. Using an in vivo model of brain iron deficiency, the Belgrade rat, we show the distribution of transferrin receptors in brain microvasculature is altered in luminal, intracellular, and abluminal membranes dependent on brain iron status. We used a cell culture model of the BBB to show the presence of factors that influence iron release in non-human primate cerebrospinal fluid and conditioned media from astrocytes; specifically apo-transferrin and hepcidin were found to increase and decrease iron release, respectively. These data have been integrated into an interactive model where BBB ECs are central in the regulation of cerebral iron metabolism.


Assuntos
Anemia Ferropriva/metabolismo , Encéfalo/metabolismo , Ferro/metabolismo , Modelos Biológicos , Anemia Ferropriva/líquido cefalorraquidiano , Anemia Ferropriva/genética , Animais , Apoproteínas/metabolismo , Astrócitos/metabolismo , Transporte Biológico , Barreira Hematoencefálica/metabolismo , Encéfalo/irrigação sanguínea , Bovinos , Células Cultivadas , Células Endoteliais/metabolismo , Feminino , Hepcidinas/metabolismo , Heterozigoto , Homozigoto , Ferro/líquido cefalorraquidiano , Macaca mulatta , Masculino , Microvasos/metabolismo , Ratos Sprague-Dawley , Receptores da Transferrina/metabolismo , Transferrina/metabolismo
5.
Am J Physiol Endocrinol Metab ; 285(4): E763-74, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12799319

RESUMO

Insulin receptor (IR) signaling cascades have been studied in many tissues, but retinal insulin action has received little attention. Retinal IR signaling and activity were investigated in vivo in rats that were freely fed, fasted, or injected with insulin by phosphotyrosine immunoblotting and by measuring kinase activity. A retina explant system was utilized to investigate the IR signaling cascade, and immunohistochemistry was used to determine which retinal cell layers respond to insulin. Basal IR activity in the retina was equivalent to that in brain and significantly greater than that of liver, and it remained constant between freely fed and fasted rats. Furthermore, IR signaling increased in the retina after portal vein administration of supraphysiological doses of insulin. Ex vivo retinas responded to 10 nM insulin with IR beta-subunit (IRbeta) and IR substrate-2 (IRS-2) tyrosine phosphorylation and AktSer473 phosphorylation. The retina expresses mRNA for all three Akt isoforms as determined by in situ hybridization, and insulin specifically increases Akt-1 kinase activity. Phospho-AktSer473 immunoreactivity increases in retinal nuclear cell layers with insulin treatment. These results demonstrate that the retinal IR signaling cascade to Akt-1 possesses constitutive activity, and that exogenous insulin further stimulates this prosurvival pathway. These findings may have implications in understanding normal and dysfunctional retinal physiology.


Assuntos
Insulina/farmacologia , Proteínas Serina-Treonina Quinases , Proteínas Proto-Oncogênicas/metabolismo , Receptor de Insulina/metabolismo , Retina/citologia , Retina/metabolismo , Animais , Ativação Enzimática , Masculino , Proteínas Proto-Oncogênicas c-akt , Ratos , Ratos Sprague-Dawley , Retina/efeitos dos fármacos , Transdução de Sinais/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA